EP2369341 - Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.05.2015 Database last updated on 24.07.2024 | Most recent event Tooltip | 15.05.2015 | Application deemed to be withdrawn | published on 17.06.2015 [2015/25] | Applicant(s) | For all designated states Arena Pharmaceuticals, Inc. 6154 Nancy Ridge Drive San Diego, CA 92121 / US | [2013/25] |
Former [2011/39] | For all designated states Arena Pharmaceuticals, Inc. 6166 Nancy Ridge Drive San Diego, CA 92121 / US | Inventor(s) | 01 /
Chu, Zhi-Liang 11489 Creekstone Lane San Diego CA 92128 / US | 02 /
Leonard, James N. 10667 Viacha Drive San Diego CA 92124 / US | [2011/39] | Representative(s) | Tollervey, Rebecca Marie, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2011/39] | Tollervey, Rebecca Marie, et al Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 10009158.6 | 10.04.2007 | [2011/39] | Priority number, date | US20060791550P | 11.04.2006 Original published format: US 791550 P | [2011/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2369341 | Date: | 28.09.2011 | Language: | EN | [2011/39] | Type: | A3 Search report | No.: | EP2369341 | Date: | 04.01.2012 | Language: | EN | [2012/01] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.12.2011 | Classification | IPC: | G01N33/50 | [2011/39] | CPC: |
G01N33/74 (EP,US);
G01N33/50 (KR);
A61P1/08 (EP);
A61P19/00 (EP);
A61P19/10 (EP);
A61P3/10 (EP);
A61P31/08 (EP);
A61P31/10 (EP);
A61P43/00 (EP);
A61P5/50 (EP);
G01N33/48 (KR);
G01N33/5005 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2011/39] | Extension states | AL | 21.09.2010 | BA | 21.09.2010 | HR | 21.09.2010 | MK | 21.09.2010 | RS | 21.09.2010 | Title | German: | Verfahren zur Verwendung des GPR119-Rezeptors zur Identifizierung von Verbindungen zur Erhöhung der Knochenmasse eines Individuums | [2011/39] | English: | Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual | [2011/39] | French: | Procédés d'utilisation de récepteur gpr119 pour identifier les composants utiles pour augmenter la masse osseuse chez un individu | [2011/39] | Examination procedure | 21.09.2010 | Examination requested [2011/39] | 18.10.2012 | Amendment by applicant (claims and/or description) | 27.06.2014 | Despatch of a communication from the examining division (Time limit: M06) | 08.01.2015 | Application deemed to be withdrawn, date of legal effect [2015/25] | 04.02.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/25] | Parent application(s) Tooltip | EP07755238.8 / EP1971862 | Divisional application(s) | EP11165164.2 / EP2402750 | EP11165314.3 / EP2410330 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 18.10.2012 | Request for further processing filed | 18.10.2012 | Full payment received (date of receipt of payment) Request granted | 30.10.2012 | Decision despatched | Fees paid | Renewal fee | 21.09.2010 | Renewal fee patent year 03 | 21.09.2010 | Renewal fee patent year 04 | 20.04.2011 | Renewal fee patent year 05 | 15.10.2012 | Renewal fee patent year 06 | 22.04.2013 | Renewal fee patent year 07 | 25.03.2014 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.04.2012 | 06   M06   Fee paid on   15.10.2012 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0187929 (BAYER AG [DE], et al) [X] 1-42 * pages 53,72-74 *; | [X]WO2004065380 (ARENA PHARM INC [US], et al) [X] 1-42 * page 127 - page 212 *; | [X]WO2005007647 (ARENA PHARM INC [US], et al) [X] 1-42 * Page 10, 127-129,146-157; page 65 - page 118 *; | [X]WO2005007658 (ARENA PHARM INC [US], et al) [X] 1-42* page 59 - page 146 *; | [X] - OVERTON HILARY A ET AL, "Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents", CELL METABOLISM, (200603), vol. 3, no. 3, ISSN 1550-4131, pages 167 - 175 URL, XP002449851 [X] 1-42 * the whole document * DOI: http://dx.doi.org/10.1016/j.cmet.2006.02.004 | [X] - MAYET S ET AL, "GPR119 activation increases glucose-dependent insulin secretion in insulin-producing cells and isolated rat islets", DIABETOLOGIA, & 41ST ANNUAL MEETING OF THE EUROPEAN-ASSOCIATION-FOR-THE-STUDY-OF-DIAB ETES; ATHENS, GREECE; SEPTEMBER 10 -15, 2005, (2005), vol. 48, no. Suppl. 1, ISSN 0012-186X, page A166, XP002449852 [X] 1-42 * abstract * |